A Multicentre Trial to Evaluate the Efficacy and Tolerability of α-Glycerylphosphorylcholine versus Cytosine Diphosphocholine in Patients with Vascular Dementia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
An open clinical trial was carried out to compare the efficacy and the tolerability of 1 g/day α-glycerylphosphorylcholine (α-GPC) with 1 g/day cytosine diphosphocholine (CDP) both given intramuscularly for 90 days in 120 patients with mild to moderate vascular dementia. The clinical evaluation, carried out at the start as well as halfway through (45 days) and at the end of treatment (90 days), was expressed by psychometric tests (modified Parkside behaviour rating scale, Sandoz clinical assessment geriatric scale, word fluency test, Hamilton's rating scale of depression, narration subtest of Wechsler memory scale). Both treatments produced a definite symptomatic improvement and showed a very good tolerability. The results suggest that in most tests α-GPC possessed a statistical higher efficacy and an overall more satisfactory activity assessed by both patients and investigators compared with CDP. E’ stato effettuato uno studio clinico in aperto per confrontare l'efficacia e la tollerabilità di α-glicerilfosforilcolina (α-GFC) alla dose di 1 g al giorno verso citosina difosfocolina (CDP) sempre alla dose di 1 g al giorno, somminístrate entrambe per via intramuscolare per 90 giorni in 120 pazienti affetti da demenza vascolare di grado da lieve a medio. La valutazione clinica, effettuata all'inizio, a metà (45 giorni) e al termine del trattamento (90 giorni), è stata effettuata con test psicometrici (modified Parkside behaviour rating scale, Sandoz clinical assessment geriatric scale, word fluency test, Hamilton rating scale per la depressione ed subtest del racconto della Wechsler memory scale). Entrambi i trattamenti hanno indotto un miglioramento della sintomatologia e hanno presentato una buona tollerabilità. I risultati mostrano che, nella maggior parte dei test, α-GFC ha presentato una più elevata efficacia, a confronto con CDP, come confermato anche dalle valutazioni soggettive espresse dai pazienti e dagli esaminatori.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093
Senile Dementia of the Binswanger Type: A Vascular Form of Dementia in the Elderly
Román, G. C. (1987) · JAMA · doi:10.1001/jama.1987.03400130096040 · Cited by 372
Cited by
Parnetti, L., Amenta, F., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00312-8 · Cited by 132
“VaD Four of these trials (Di Perri et al., 1991; Frattola et al., 1991; Muratorio et al., 1992; Paciaroni and Tomassini, 1993) considered homogeneous cases and were controlled versus reference drug (see Table 1, column 2).”
BackgroundCholine supplements: An update
Kansakar, U., Trimarco, V., Mone, P., Varzideh, F., Lombardi, A., & Santulli, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1148166 · Cited by 103
Hoffman, J. R., Ratamess, N. A., Gonzalez, A., Beller, N. A., Hoffman, M. W., Olson, M., Purpura, M., & Jäger, R. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-39 · Cited by 34
Metadata
- Authors
- Perri, R. D., Coppola, G., Ambrosio, L. A., Grasso, A., Puca, F. M., & Rizzo, M.
- Venue
- Journal of International Medical Research
- Publisher
- SAGE Publications
- Published
- 1991-07
- Volume
- 19
- Issue
- 4
- Pages
- 330-341
- ISSN
- 0300-0605 (ISSN-L)
- 1473-2300
- OpenAlex
- W2116407743
- Cited by
- 45
- References
- 2
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Multicentre Trial to Evaluate the Efficacy and Tolerability of α-Glycerylphosphorylcholine versus Cytosine Diphosphocholine in Patients with Vascular Dementia. https://app.cochat.ai/papers/10.1177/030006059101900406
- The paper
- Perri, R. D., Coppola, G., Ambrosio, L. A., Grasso, A., Puca, F. M., & Rizzo, M. (1991). A Multicentre Trial to Evaluate the Efficacy and Tolerability of α-Glycerylphosphorylcholine versus Cytosine Diphosphocholine in Patients with Vascular Dementia. Journal of International Medical Research. https://doi.org/10.1177/030006059101900406
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.